Judges reaffirm that stem cells fall under aegis of FDA

court full
CREDIT: Wikimedia, Anoko

The D.C. Circuit Court of Appeals ruled this week (February 4) that culturing a patient’s stem cells for therapeutic use falls under the aegis of the US Food and Drug Administration (FDA). FDA has said therapeutic stem cells should be regulated as drugs.

“It is much too simplistic to think that stem cells are removed from the body and then returned to the body without a ‘manufacturing process’ that includes risk of transmission of communicable diseases,” Leigh Turner, a bioethicist at the University of Minnesota, told Nature News in 2012 following a ruling by the US District Court in Washington, D.C. “Maintaining the FDA’s role as watchdog and regulatory authority is imperative,” Turner added.

This week’s decision upheld that earlier ruling.

Read the full, original article: Judges Side with FDA on Stem Cells

Additional Resources:


Outbreak Daily Digest
Biotech Facts & Fallacies
Genetics Unzipped
Infographic: How dangerous COVID mutant strains develop

Infographic: How dangerous COVID mutant strains develop

Sometime in 2019, probably in China, SARS CoV-2 figured out a way to interact with a specific "spike" on the ...

Philip Njemanze: Leading African anti-GMO activist claims Gates Foundation destroying Nigeria

Nigerian anti-GMO activist, physician, and inventor pushes anti-gay and anti-GMO ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend